Entebbe, Uganda — The Eastern Africa Consortium for Clinical Research (EACCR) has launched its fourth phase, EACCR4, marking a major advance in African-led public health preparedness and outbreak response.
Supported by a €12 million (approximately Shs 50 billion) investment from the Global Health EDCTP3 partnership, the four-year initiative was formally inaugurated on 10 September 2026 at the Uganda Virus Research Institute (UVRI).
